You are here

Clinical Trials: Eye Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, May 24, 2017 - 19:00
Condition:   Non Arteritic Ischemic Optic Neuropathy
Intervention:   Procedure: intravitreal injection of MSV
Sponsors:   Instituto Universitario de Oftalmobiología Aplicada;   University of Valladolid
Not yet recruiting - verified June 2017
Posted: Wednesday, May 24, 2017 - 19:00
Condition:   Age-Related Macular Degeneration
Interventions:   Drug: ASP7317;   Other: Placebo;   Drug: Prograf®;   Drug: mycophenolate mofetil (MMF)
Sponsor:   Astellas Institute for Regenerative Medicine
Not yet recruiting - verified June 2017
Posted: Thursday, March 2, 2017 - 20:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: human retinal progenitor cells
Sponsor:   jCyte, Inc
Recruiting - verified March 2017
Posted: Thursday, February 2, 2017 - 20:00
Condition:   Dry Age-related Macular Degeneration
Intervention:   Biological: retinal pigment epithelium transplantation
Sponsors:   Chinese Academy of Sciences;   The First Affiliated Hospital of Zhengzhou University
Recruiting - verified December 2016
Posted: Sunday, January 1, 2017 - 20:00
Conditions:   Retinal Disease;   Age-Related Macular Degeneration;   Retinitis Pigmentosa;   Stargardt Disease;   Optic Neuropathy;   Nonarteritic Ischemic Optic Neuropathy;   Optic Atrophy;   Optic Nerve Disease;   Glaucoma;   Leber Hereditary Optic Neuropathy
Interventions:   Procedure: Arm 1;   Procedure: Arm 2;   Procedure: Arm 3
Sponsor:   MD Stem Cells
Recruiting - verified January 2017
Posted: Thursday, October 20, 2016 - 19:00
Conditions:   Corneal Injuries;   Corneal Burns;   Corneal Scars and Opacities
Intervention:   Biological: Ex-vivo cultivated limbal stem cell pool
Sponsor:   L.V. Prasad Eye Institute
Recruiting - verified October 2016
Posted: Sunday, October 2, 2016 - 19:00
Conditions:   Hereditary Corneal Dystrophy;   Keratoconus
Interventions:   Procedure: Lipoaspiration;   Procedure: Transplantation
Sponsors:   Vissum, Instituto Oftalmológico de Alicante;   Reviva Pharmaceuticals;   Hospital Universitario La Paz;   LASER VISION CENTER IN LIBANON;   OPTICA GENERAL IN LIBANON
Recruiting - verified October 2016
Posted: Monday, August 1, 2016 - 19:00
Condition:   Glaucoma
Interventions:   Drug: NT-501 ECT implant;   Other: Sham
Sponsor:   Stanford University
Recruiting - verified August 2016
Posted: Saturday, March 26, 2016 - 19:00
Condition:   Dry Age-related Macular Degeneration
Intervention:   Biological: retinal pigment epithelium transplantation
Sponsors:   Chinese Academy of Sciences;   Beijing Tongren Hospital
Recruiting - verified December 2016
Posted: Monday, March 7, 2016 - 20:00
Conditions:   Age Related Macular Degeneration;   Stargardt's Disease;   Exudative Age-related Macular Degeneration
Interventions:   Procedure: injection of hESC-RPE in suspension;   Procedure: injection hESC-RPE seeded in a substrate
Sponsor:   Federal University of São Paulo
Recruiting - verified September 2016

Pages